PETER J POLVERINI, DDS, DMSC
Medical Practice at University Ave, Ann Arbor, MI

License number
Michigan 2901016040
Category
Dentist
Type
Dentist
License number
Michigan 2901016040
Category
Dentist
Type
Oral and Maxillofacial Pathology
License number
Michigan 2901016040
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address 2
1011 N University Ave, Ann Arbor, MI 48109
5700 Southwyck Blvd, Toledo, OH 43614
Phone
(734) 763-6933
(734) 763-5142 (Fax)
(800) 288-8325
(419) 866-5453 (Fax)

Personal information

See more information about PETER J POLVERINI at radaris.com
Name
Address
Phone
Peter Polverini
125 Township Road 1283, Bloomingdale, OH 43910
Peter Polverini
2630 Pin Oak Dr APT 41, Ann Arbor, MI 48103
Peter Polverini
5229 W Michigan Ave LOT 102, Ypsilanti, MI 48197
Peter J. Polverini
Ann Arbor, MI
(734) 769-5108
Peter Polverini
2630 Pin Oak Dr, Ann Arbor, MI 48103

Professional information

Peter Polverini Photo 1

Professor Of Dentistry At University Of Michigan Dental School

Position:
Professor of Dentistry and Pathology at University of Michigan Dental and Medical Schools, Professor of Pathology at University of Michigan Medical School, Professor of Dentistry at University of Michigan Dental School
Location:
Greater Detroit Area
Industry:
Higher Education
Work:
University of Michigan Dental and Medical Schools - University of Michigan since Jun 2003 - Professor of Dentistry and Pathology University of Michigan Medical School since Sep 1992 - Professor of Pathology University of Michigan Dental School - Ann Arbor, MI since 1992 - Professor of Dentistry Northwestern University Aug 1981 - Jul 1992 - Associate Professor of Pathology University of Pittsburgh Aug 1977 - Jul 1980 - Assistant Professor of Diagnostic Sciences
Education:
Harvard University 1973 - 1977
DMSc, Oral Biology/Experimental Pathology
Marquette University 1969 - 1973
DDS, Dentistry
Marquette University 1965 - 1969
BS, Biology
Honor & Awards:
Diplomate, American Board of Oral nad Maxillofacial Pathology Fellow, Americam Association for the Advancement of Science American College of Dentists International College of Dentists Member, Institute of Medicine


Peter J Polverini Photo 2

Dr. Peter J Polverini, Ann Arbor MI - DDS (Doctor of Dental Surgery)

Specialties:
Oral & Maxillofacial Pathology
Address:
1011 N University Ave, Ann Arbor 48109
(734) 763-3311 (Phone), (734) 763-5142 (Fax)
Languages:
English
Education:
Medical School
Graduates of Institutions Not Listed As Medical Schools


Peter Polverini Photo 3

Cxc Chemokines As Regulators Of Angiogenesis

US Patent:
6491906, Dec 10, 2002
Filed:
Dec 9, 1998
Appl. No.:
09/213383
Inventors:
Robert M. Strieter - Ann Arbor MI
Peter J. Polverini - Ann Arbor MI
Steven L. Kunkel - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A01N 6300
US Classification:
424 932, 4353201, 435325, 424 852, 4241991, 514 44
Abstract:
Disclosed are various discoveries concerning the angiogenic and angiostatic properties of the CXC chemokines, including the finding that the ELR motif controls the ability of these molecules to induce angiogenesis. Aspects of the invention include, for example, the identification of IP-10, MIG and certain IL-8 analogues as angiostatic agents, and their use in inhibiting angiogenesis in various systems.


Peter John Polverini Photo 4

Peter John Polverini, Ann Arbor MI

Specialties:
Dentist
Address:
1011 N University Ave, Ann Arbor, MI 48109


Peter Polverini Photo 5

Treatment Of Kaposi's Sarcoma By Inhibition Of Scatter Factor

US Patent:
5707624, Jan 13, 1998
Filed:
Jun 3, 1994
Appl. No.:
8/253728
Inventors:
Brian J. Nickoloff - Dexter MI
Yahti M. Naidu - San Diego CA
Eliot M. Rosen - Port Washington NY
Peter J. Polverini - Ann Arbor MI
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39395
US Classification:
4241581
Abstract:
Methods of treating Kaposi's sarcoma (KS) by inhibiting the effect of scatter factor (SF), also known as hepatocyte growth factor (HGF), are provided. The methods of the present invention include antibody therapy wherein an antibody to SF is introduced into a patient to decrease active SF levels thereby decreasing the incidence of new tumors as well as leading to regression of established tumors by blocking SF-mediated tumor cell proliferation and neovascularization. The present invention further provides methods of inhibiting the effects of SF by introducing into a patient means for inhibiting binding of SF to the SF receptor, the c-met proto-oncogen. Means for inhibiting SF binding to the receptor include introducing into a patient an antibody to the c-met receptor or introducing a non-stimulatory ligand that will bind and thereby inhibit the receptor.


Peter Polverini Photo 6

Cxc Chemokines As Regulators Of Angiogenesis

US Patent:
5871723, Feb 16, 1999
Filed:
Jun 6, 1995
Appl. No.:
8/468819
Inventors:
Robert M. Strieter - Ann Arbor MI
Peter J. Polverini - Ann Arbor MI
Steven L. Kunkel - Ann Arbor MI
Assignee:
The Regent of the University of Michigan - Ann Arbor MI
International Classification:
A61K 3819
US Classification:
424 851
Abstract:
Disclosed are various discoveries concerning the angiogenic and angiostatic properties of the CXC chemokines, including the finding that the ELR motif controls the ability of these molecules to induce angiogenesis. Aspects of the invention include, for example, the identification of IP-10, MIG and certain IL-8 analogues as angiostatic agents, and their use in inhibiting angiogenesis in various systems.